SEC Form 4 · accession 0001445064-15-000111
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — SVP, Investor Strategy & IRO
Period of report
Aug 21, 2015
Accepted (ET)
Aug 24, 2015 · 7:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Aug 21, 2015 | P | 1,900 | $88.49 | A | 7,361 | D | |
| Ordinary Shares | Aug 21, 2015 | P | 400 | $88.77 | A | 500 | I | By wife |
| Ordinary Shares | Aug 21, 2015 | P | 45 | $87.88 | A | 75 | I | By son (M) |
| Ordinary Shares | Aug 21, 2015 | P | 15 | $87.77 | A | 45 | I | By son (R) |
| Ordinary Shares | Aug 21, 2015 | P | 15 | $87.77 | A | 45 | I | By son (S) |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $88.44 to $88.55, inclusive. Mr. Lannum will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
- F2Includes 29 shares acquired on June 4, 2015, 19 shares acquired on July 7, 2015 and 23 shares acquired on August 5, 2015 under the Mallinckrodt employee stock purchase plan.